BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 8747402)

  • 1. Early detection and screening for ovarian cancer.
    Schwartz PE; Chambers JT; Taylor KJ
    J Cell Biochem Suppl; 1995; 23():233-7. PubMed ID: 8747402
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early detection of ovarian cancer: preliminary results of the Yale Early Detection Program.
    Schwartz PE; Chambers JT; Taylor KJ; Pellerito J; Hammers L; Cole LA; Yang-Feng TL; Smith P; Mayne ST; Makuch R
    Yale J Biol Med; 1991; 64(6):573-82. PubMed ID: 1810101
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of ultrasound evaluation in the detection of early-stage epithelial ovarian cancer.
    Fishman DA; Cohen L; Blank SV; Shulman L; Singh D; Bozorgi K; Tamura R; Timor-Tritsch I; Schwartz PE
    Am J Obstet Gynecol; 2005 Apr; 192(4):1214-21; discussion 1221-2. PubMed ID: 15846205
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early detection of ovarian cancer: background, rationale, and structure of the Yale Early Detection Program.
    Schwartz PE; Chambers JT; Taylor KJ; Pellerito J; Hammers L; Cole LA; Yang-Feng TL; Smith P; Mayne ST; Makuch R
    Yale J Biol Med; 1991; 64(6):557-71. PubMed ID: 1810100
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention and early detection of ovarian cancer: mission impossible?
    Bast RC; Brewer M; Zou C; Hernandez MA; Daley M; Ozols R; Lu K; Lu Z; Badgwell D; Mills GB; Skates S; Zhang Z; Chan D; Lokshin A; Yu Y
    Recent Results Cancer Res; 2007; 174():91-100. PubMed ID: 17302189
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk assessment for epithelial ovarian cancer: proposing a new approach to a deadly problem.
    Chu MM; Fishman D
    Scand J Clin Lab Invest Suppl; 2014; 244():63-7; discussion 66-7. PubMed ID: 25083896
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical Use of Cancer Biomarkers in Epithelial Ovarian Cancer: Updated Guidelines From the European Group on Tumor Markers.
    Sölétormos G; Duffy MJ; Othman Abu Hassan S; Verheijen RH; Tholander B; Bast RC; Gaarenstroom KN; Sturgeon CM; Bonfrer JM; Petersen PH; Troonen H; CarloTorre G; Kanty Kulpa J; Tuxen MK; Molina R
    Int J Gynecol Cancer; 2016 Jan; 26(1):43-51. PubMed ID: 26588231
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
    Piver MS
    Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is early detection of ovarian cancer possible?
    Schwartz PE; Taylor KJ
    Ann Med; 1995 Oct; 27(5):519-28. PubMed ID: 8541026
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New tumor markers: CA125 and beyond.
    Bast RC; Badgwell D; Lu Z; Marquez R; Rosen D; Liu J; Baggerly KA; Atkinson EN; Skates S; Zhang Z; Lokshin A; Menon U; Jacobs I; Lu K
    Int J Gynecol Cancer; 2005; 15 Suppl 3():274-81. PubMed ID: 16343244
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of HE4, CA125, risk of ovarian malignancy algorithm (ROMA) and risk of malignancy index (RMI) as diagnostic tools of epithelial ovarian cancer in patients with a pelvic mass.
    Karlsen MA; Sandhu N; Høgdall C; Christensen IJ; Nedergaard L; Lundvall L; Engelholm SA; Pedersen AT; Hartwell D; Lydolph M; Laursen IA; Høgdall EV
    Gynecol Oncol; 2012 Nov; 127(2):379-83. PubMed ID: 22835718
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of HE4, CA125, and Risk of Ovarian Malignancy Algorithm in the Prediction of Ovarian Cancer in Korean Women.
    Cho HY; Park SH; Park YH; Kim HB; Kang JB; Hong SH; Kyung MS
    J Korean Med Sci; 2015 Dec; 30(12):1777-83. PubMed ID: 26713052
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical validation of multiple biomarkers suspension array technology for ovarian cancer].
    Zhao BB; Yang ZJ; Wang Q; Pan ZM; Zhang W; Li L
    Zhonghua Fu Chan Ke Za Zhi; 2017 Jan; 52(1):11-19. PubMed ID: 28190310
    [No Abstract]   [Full Text] [Related]  

  • 14. Biology of epithelial ovarian cancer: implications for screening women at high genetic risk.
    Hogg R; Friedlander M
    J Clin Oncol; 2004 Apr; 22(7):1315-27. PubMed ID: 15051780
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer screening in a high risk population: a clinical trial.
    Taylor KJ; Schwartz PE
    Ultrasound Med Biol; 2001 Apr; 27(4):461-6. PubMed ID: 11368858
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Pilot Study of Circulating MicroRNA-125b as a Diagnostic and Prognostic Biomarker for Epithelial Ovarian Cancer.
    Zhu T; Gao W; Chen X; Zhang Y; Wu M; Zhang P; Wang S
    Int J Gynecol Cancer; 2017 Jan; 27(1):3-10. PubMed ID: 27636713
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Program for early detection of ovarian cancer for women as prophylaxis provided at a municipal hospital].
    Cnota W; Sodowski K; Olesiak-Andryszczak M; Pilch-Kowalczyk M
    Wiad Lek; 2004; 57 Suppl 1():43-7. PubMed ID: 15884203
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ovarian cancer screening in women with a family history of breast or ovarian cancer.
    Lacey JV; Greene MH; Buys SS; Reding D; Riley TL; Berg CD; Fagerstrom RM; Hartge P
    Obstet Gynecol; 2006 Nov; 108(5):1176-84. PubMed ID: 17077240
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Protein levels and its clinical significance of septin-9 and clusterin in peripheral blood of epithelial ovarian cancer patients].
    Lyu N; Yao H; Xiao T; Gao Y; Wu L
    Zhonghua Fu Chan Ke Za Zhi; 2015 Sep; 50(9):679-84. PubMed ID: 26675395
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence in a volunteer population of pelvic cancer detected with transvaginal ultrasound and color flow Doppler.
    Schulman H; Conway C; Zalud I; Farmakides G; Haley J; Cassata M
    Ultrasound Obstet Gynecol; 1994 Sep; 4(5):414-420. PubMed ID: 12797152
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.